SCHEMBL906527

SCHEMBL906527

CCCC(=O)NCc1ccc(O)c(OC)c1

nearest known ligand 0.81

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.81
CYP3A4 P08684 2/20 0.81
CYP2D6 P10635 2/20 0.81
HPGD P15428 2/20 0.81
ALDH1A1 P00352 1/20 0.81
CYP2C9 P11712 1/20 0.81
ALOX15 P16050 1/20 0.81
CYP2C19 P33261 1/20 0.81
BLM P54132 1/20 0.81
PMP22 Q01453 1/20 0.81
TRPV1 Q8NER1 8/20 0.75
MEN1 O00255 1/20 0.70
TP53 P04637 1/20 0.70
MAPT P10636 1/20 0.70
MTOR P42345 1/20 0.70
KMT2A Q03164 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3266072 0.92 HPGD (0.90) CYP1A2CYP3A4CYP2D6HPGDALDH1A1
SCHEMBL15259678 0.91 HPGD (0.97) CYP1A2CYP3A4CYP2D6HPGDALDH1A1
Nonivamide SCHEMBL81939 0.89 CYP1A2 (1.00) CYP1A2CYP3A4CYP2D6HPGDALDH1A1
SCHEMBL5088067 0.89 CYP1A2 (1.00) CYP1A2CYP3A4CYP2D6HPGDALDH1A1
SCHEMBL5889449 0.89 CYP1A2 (1.00) CYP1A2CYP3A4CYP2D6HPGDALDH1A1
SCHEMBL679954 0.89 CYP1A2 (1.00) CYP1A2CYP3A4CYP2D6HPGDALDH1A1
SCHEMBL1155739 0.89 CYP1A2 (1.00) CYP1A2CYP3A4CYP2D6HPGDALDH1A1
SCHEMBL2400979 0.89 CYP1A2 (1.00) CYP1A2CYP3A4CYP2D6HPGDALDH1A1
SCHEMBL8373082 0.89 CYP1A2 (1.00) CYP1A2CYP3A4CYP2D6HPGDALDH1A1
SCHEMBL1155582 0.89 CYP1A2 (1.00) CYP1A2CYP3A4CYP2D6HPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102006786-B Warming sensate composition FIRMENICH S.A. (CH) 2014-10-01 CN claimed
EP-2276356-B1 WARMING SENSATE COMPOSITION FIRMENICH & CIE (CH) 2013-06-19 EP claimed
CN-101155522-B Hot flavour and skin sensation composition FIRMENICH & CIE 2011-08-24 CN claimed
CN-102006786-A Warming sensate composition FIRMENICH & CIE 2011-04-06 CN claimed
EP-2276356-A1 WARMING SENSATE COMPOSITION Firmenich S.A. (CH) 2011-01-26 EP claimed
US-20110015227-A1 WARMING SENSATE COMPOSITION FIRMENICH SA (CH) 2011-01-20 US claimed
WO-2009127992-A1 WARMING SENSATE COMPOSITION FIRMENICH SA (CH) 2009-10-22 WO claimed
CN-101155522-A Hot flavour and skin sensation composition FIRMENICH & CIE (CH) 2008-04-02 CN claimed
EP-1874132-A1 HOT FLAVOUR AND SKIN SENSATION COMPOSITION FIRMENICH SA (CH) 2008-01-09 EP claimed
US-20080000614-A1 HOT FLAVOR AND SKIN SENSATION COMPOSITION FIRMENICH SA (CH) 2008-01-03 US claimed
WO-2006109241-A1 HOT FLAVOUR AND SKIN SENSATION COMPOSITION FIRMENICH SA (CH) 2006-10-19 WO claimed
US-20200157338-A1 SELF-POLISHING ZWITTERIONIC ANTI-FOULING RESIN HAVING MAIN CHAIN DEGRADABILITY AND PREPARATION THEREFOR AND USE THEREOF SOUTH CHINA UNIVERSITY OF TECHNOLOGY (CN) 2020-05-21 US disclosed
WO-2012175276-A1 TASTE MODIFYING COMPOUND INCLUDING EVODIAMINE FIRMENICH SA (CH) 2012-12-27 WO disclosed
CN-101155522-B Hot flavour and skin sensation composition FIRMENICH & CIE 2011-08-24 CN disclosed
US-7736661-B1 Method of treating skin conditions AVON PRODUCTS, INC (US) 2010-06-15 US disclosed
EP-1173148-A4 METHOD OF IMPROVING THE AESTHETIC APPEARANCE OF EPITHELIA AVON PROD INC (US) 2002-07-24 EP disclosed
EP-1173148-A1 METHOD OF IMPROVING THE AESTHETIC APPEARANCE OF EPITHELIA AVON PRODUCTS, INC. (US) 2002-01-23 EP disclosed
EP-1136064-A2 Method for improving the apperance of skin and topical compositions for practicing the same AVON PRODUCTS, INC. (US) 2001-09-26 EP disclosed
WO-2001066067-A1 METHOD OF TREATING SKIN CONDITIONS AVON PRODUCTS, INC. (US) 2001-09-13 WO disclosed
WO-2000066077-A1 METHOD OF IMPROVING THE AESTHETIC APPEARANCE OF EPITHELIA AVON PRODUCTS, INC. (US) 2000-11-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110015227-A1 WARMING SENSATE COMPOSITION TAS1R3, TAS2R30, TAS2R50 CYP1A2 1073/4885CYP3A4 2127/4885CYP2D6 2319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.